Managing the TME to improve the efficacy of cancer therapy von Bilotta, Maria Teresa, Antignani, Antonella, Fitzgerald, David J.

Volltext

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia von Haso, Waleed, Lee, Daniel W., Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Pastan, Ira H., Dimitrov, Dimiter S., Morgan, Richard A., FitzGerald, David J., Barrett, David M., Wayne, Alan S., Mackall, Crystal L., Orentas, Rimas J.

Volltext

Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia von KREITMAN, Robert J, TALLMAN, Martin S, ROBAK, Tadeusz, COUTRE, Steven, WILSON, Wyndham H, STETLER-STEVENSON, Maryalice, FITZGERALD, David J, LECHLEIDER, Robert, PASTAN, Ira

Volltext

Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P von KREITMAN, Robert J, HASSAN, Raffit, FITZGERALD, David J, PASTAN, Ira

Volltext

Immunotoxins for leukemia von Wayne, Alan S., FitzGerald, David J., Kreitman, Robert J., Pastan, Ira

Volltext

Immunotoxin treatment of cancer von Pastan, Ira, Hassan, Raffit, FitzGerald, David J, Kreitman, Robert J

Volltext

Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia von KREITMAN, Robert J, STETLER-STEVENSON, Maryalice, MARGULIES, Inger, NOEL, Pierre, FITZGERALD, David J. P, WILSON, Wyndham H, PASTAN, Ira

Volltext

Identification of Tandem Duplicate Regulatory Small RNAs in Pseudomonas aeruginosa Involved in Iron Homeostasis von Wilderman, Paula J., Sowa, Nathaniel A., FitzGerald, David J., FitzGerald, Peter C., Gottesman, Susan, Ochsner, Urs A., Vasil, Michael L.

Volltext

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial von WAYNE, Alan S, KREITMAN, Robert J, FINDLEY, Harry W, LEW, Glen, DELBROOK, Cynthia, STEINBERG, Seth M, STETLER-STEVENSON, Maryalice, FITZGERALD, David J, PASTAN, Ira

Volltext

Pseudomonas Exotoxin A-Mediated Apoptosis Is Bak Dependent and Preceded by the Degradation of Mcl-1 von Du, Xing, Youle, Richard J., FitzGerald, David J., Pastan, Ira

Volltext

Targeting Receptors on Cancer Cells with Protein Toxins von Antignani, Antonella, Ho, Eric Chun Hei, Bilotta, Maria Teresa, Qiu, Rong, Sarnvosky, Robert, FitzGerald, David J.

Volltext

Cell-specific cargo delivery using synthetic bacterial spores von Kong, Minsuk, D’Atri, Domenico, Bilotta, Maria Teresa, Johnson, Bailey, Updegrove, Taylor B., Gallardo, Devorah L., Machinandiarena, Federico, Wu, I-Lin, Constantino, Maira Alves, Hewitt, Stephen M., Tanner, Kandice, Fitzgerald, David J., Ramamurthi, Kumaran S.

Volltext

Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia von Kreitman, Robert J, Wilson, Wyndham H, Bergeron, Karen, Raggio, Miranda, Stetler-Stevenson, Maryalice, FitzGerald, David J, Pastan, Ira

Volltext

Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins von Antignani, Antonella, Mathews Griner, Lesley, Guha, Rajarshi, Simon, Nathan, Pasetto, Matteo, Keller, Jonathan, Huang, Manjie, Angelus, Evan, Pastan, Ira, Ferrer, Marc, FitzGerald, David J, Thomas, Craig J

Volltext

Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity von Pasetto, Matteo, Antignani, Antonella, Ormanoglu, Pinar, Buehler, Eugen, Guha, Rajarshi, Pastan, Ira, Martin, Scott E., FitzGerald, David J.

Volltext

Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy von Wei, Hui, Xiang, Laiman, Wayne, Alan S, Chertov, Oleg, FitzGerald, David J, Bera, Tapan K, Pastan, Ira

Volltext

Immunotoxin therapy of cancer von Pastan, Ira, Hassan, Raffit, FitzGerald, David J, Kreitman, Robert J

Volltext

Targeted diphtheria toxin to treat BPDCN von FitzGerald, David J.

Volltext

Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates von FITZGERALD, David J, WAYNE, Alan S, KREITMAN, Robert J, PASTAN, Ira

Volltext

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up von Kreitman, Robert J., Tallman, Martin S., Robak, Tadeusz, Coutre, Steven, Wilson, Wyndham H., Stetler-Stevenson, Maryalice, FitzGerald, David J., Santiago, Linda, Gao, Guozhi, Lanasa, Mark C., Pastan, Ira

Volltext